Matches in Wikidata for { <http://www.wikidata.org/entity/Q39085623> ?p ?o ?g. }
- Q39085623 description "2013 nî lūn-bûn" @default.
- Q39085623 description "2013 թվականի հոկտեմբերի 4-ին հրատարակված գիտական հոդված" @default.
- Q39085623 description "2013年の論文" @default.
- Q39085623 description "2013年論文" @default.
- Q39085623 description "2013年論文" @default.
- Q39085623 description "2013年論文" @default.
- Q39085623 description "2013年論文" @default.
- Q39085623 description "2013年論文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013年论文" @default.
- Q39085623 description "2013년 논문" @default.
- Q39085623 description "article científic" @default.
- Q39085623 description "article scientific" @default.
- Q39085623 description "article scientifique" @default.
- Q39085623 description "articol științific" @default.
- Q39085623 description "articolo scientifico" @default.
- Q39085623 description "artigo científico" @default.
- Q39085623 description "artigo científico" @default.
- Q39085623 description "artigo científico" @default.
- Q39085623 description "artikel ilmiah" @default.
- Q39085623 description "artikull shkencor" @default.
- Q39085623 description "artikulong pang-agham" @default.
- Q39085623 description "artykuł naukowy" @default.
- Q39085623 description "artículo científico publicado en 2013" @default.
- Q39085623 description "artículu científicu espublizáu en 2013" @default.
- Q39085623 description "bilimsel makale" @default.
- Q39085623 description "bài báo khoa học" @default.
- Q39085623 description "naučni članak" @default.
- Q39085623 description "scienca artikolo" @default.
- Q39085623 description "scientific article published on 4 October 2013" @default.
- Q39085623 description "scientific article published on 4 October 2013" @default.
- Q39085623 description "scientific article published on 4 October 2013" @default.
- Q39085623 description "teaduslik artikkel" @default.
- Q39085623 description "tieteellinen artikkeli" @default.
- Q39085623 description "tudományos cikk" @default.
- Q39085623 description "vedecký článok" @default.
- Q39085623 description "vetenskaplig artikel" @default.
- Q39085623 description "videnskabelig artikel" @default.
- Q39085623 description "vitenskapelig artikkel" @default.
- Q39085623 description "vitskapeleg artikkel" @default.
- Q39085623 description "vědecký článek" @default.
- Q39085623 description "wetenschappelijk artikel" @default.
- Q39085623 description "wissenschaftlicher Artikel" @default.
- Q39085623 description "επιστημονικό άρθρο" @default.
- Q39085623 description "мақолаи илмӣ" @default.
- Q39085623 description "наукова стаття, опублікована в жовтні 2013" @default.
- Q39085623 description "научна статия" @default.
- Q39085623 description "научная статья" @default.
- Q39085623 description "научни чланак" @default.
- Q39085623 description "научни чланак" @default.
- Q39085623 description "מאמר מדעי" @default.
- Q39085623 description "مقالة علمية نشرت في 4 أكتوبر 2013" @default.
- Q39085623 description "৪ অক্টোবর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q39085623 description "บทความทางวิทยาศาสตร์" @default.
- Q39085623 description "სამეცნიერო სტატია" @default.
- Q39085623 name "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 name "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 type Item @default.
- Q39085623 label "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 label "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 prefLabel "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 prefLabel "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy." @default.
- Q39085623 P1433 Q39085623-E6582D02-8251-45C9-8FDA-139E635CF8E2 @default.
- Q39085623 P1476 Q39085623-8534F7ED-3F45-4AD5-8893-1FE74B95B7AB @default.
- Q39085623 P2093 Q39085623-2E0FFA23-1850-42A0-9576-E0B15690920E @default.
- Q39085623 P2093 Q39085623-320E3D33-56C1-41EC-BDDF-B772103C9EEF @default.
- Q39085623 P2093 Q39085623-3D404919-DCBE-422B-AF31-7585425FE115 @default.
- Q39085623 P2093 Q39085623-3F8B3FB5-13EC-464D-B6B3-8019423A0944 @default.
- Q39085623 P2093 Q39085623-620E2095-5A5B-4A0F-B5B7-F74556355EB6 @default.
- Q39085623 P2093 Q39085623-8FAEACBF-82B9-444D-BA9C-B146DD435407 @default.
- Q39085623 P2093 Q39085623-982DA06C-96CA-49F9-98ED-71FB563A9FA5 @default.
- Q39085623 P2093 Q39085623-988E99B1-6B6A-419B-9EBD-AEB9C580C7C3 @default.
- Q39085623 P2093 Q39085623-B048DCF9-B98F-4660-9236-16AF635A1171 @default.
- Q39085623 P2093 Q39085623-D3B491CA-6E75-4A67-B86D-896D05C21E3C @default.
- Q39085623 P2093 Q39085623-D9FBF74C-E5F7-4A44-A822-112CA088BA89 @default.
- Q39085623 P2093 Q39085623-E2EC6A21-0F8C-4028-A00D-A178DE1BE0BC @default.
- Q39085623 P2093 Q39085623-E969AA65-BDAB-416F-82DD-2F6259C3B993 @default.
- Q39085623 P2093 Q39085623-F34EBAD9-8FC6-4101-81EA-94D60E8BB8EC @default.
- Q39085623 P2093 Q39085623-FEAEDC37-E5ED-4125-88C4-853AC3FDE6E0 @default.
- Q39085623 P2860 Q39085623-0307B49C-2341-44C8-B0A5-69ACF3D5AC30 @default.
- Q39085623 P2860 Q39085623-1B1D2CDD-9390-460B-8E8A-77A5B682F678 @default.
- Q39085623 P304 Q39085623-158799AB-410D-4EC7-BE47-A4659916172C @default.
- Q39085623 P31 Q39085623-17BE7319-5A2B-49BC-B886-934830455D89 @default.
- Q39085623 P356 Q39085623-E2F630E1-D004-49DC-B06D-660D7989ABA5 @default.
- Q39085623 P407 Q39085623-8C7D9937-3D7F-4583-B0A2-4FDBCAEAE548 @default.
- Q39085623 P433 Q39085623-A46DE515-CF03-45C7-988C-7EB89E3A7C0A @default.
- Q39085623 P478 Q39085623-CB8AE884-503D-4BED-86AE-073DA325C95A @default.
- Q39085623 P50 Q39085623-D5D7A4F8-D677-440C-9F83-DE60E1F932B6 @default.
- Q39085623 P50 Q39085623-E23BAA8C-C815-438E-BED9-697D28CED8B8 @default.
- Q39085623 P577 Q39085623-1A427F90-4924-48CC-BAEE-72912E77619E @default.
- Q39085623 P698 Q39085623-E183AE72-3203-4EB4-B899-D19796C3C4A4 @default.
- Q39085623 P921 Q39085623-F57EB2B4-2E46-42A8-8576-B60E244FF36E @default.
- Q39085623 P356 1078-0432.CCR-13-0358 @default.
- Q39085623 P698 24097864 @default.
- Q39085623 P1433 Q332253 @default.
- Q39085623 P1476 "Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy" @default.